If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTmt Investments Regulatory News (TMT)

Share Price Information for Tmt Investments (TMT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.40
Ask: 3.56
Change: -0.01 (-0.29%)
Spread: 0.16 (4.706%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.49
TMT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shareholder Loan and Amendment of Bonus Plan

25 Nov 2020 07:00

RNS Number : 3884G
TMT Investments PLC
25 November 2020
 

25 November 2020

 

TMT INVESTMENTS Plc

("TMT" or the "Company")

 

Shareholder loan

and

Extension and amendment of the Bonus Plan

 

TMT Investments Plc (AIM: TMT.L), the venture capital company investing in high-growth technology companies, announces the following corporate developments.

 

Zero-interest shareholder loan

As announced on 12 November 2020, following the agreed disposal of the Company's equity interest in Pipedrive Inc., TMT expects the receipt of approximately US$41 million (the "Consideration") by the end of 2020.

 

TMT notes that the size of the Company's current pipeline of new proposed investments which, if approved by TMT's formal investment committee, may be ready to close prior to TMT's receipt of the Consideration, exceeds the size of the Company's current cash reserves.

 

As the Company does not want to slow down its investing activities and potentially miss attractive investment opportunities, the Company has entered into a loan agreement with Macmillan Trading Company Limited ("Macmillan"), for a loan of up to US$5.0 million (the "Loan"). The Loan, which is unsecured and incurs no interest or other fees and is repayable any time before 31 December 2021, will allow the Company to continue to make investments prior to the Consideration being received.

 

Macmillan is owned by German Kaplun, Artemii Iniutin and Alexander Morgulchik, who are all part of the Company's senior management team. Mr Kaplun and Mr Morgulchik are also substantial shareholders, as defined in the AIM Rules for Companies ("AIM Rules"), in the Company ("Substantial Shareholders") and hence are deemed to be related parties pursuant to the AIM Rules. Accordingly, the Loan represents a related party transaction under Rule 13 of the AIM Rules. The Directors consider, having consulted with the Company's Nominated Adviser, Strand Hanson Limited, that the terms of the Loan are fair and reasonable insofar as the Company's shareholders are concerned.

 

Extension of and amendments to the Bonus Plan

As announced on 2 December 2015, with effect from 1 July 2015, the Company adopted a bonus plan for certain of the Directors, officers, employees of and/or consultants to the Company and/or any company directly or indirectly controlled by the Company, the rationale for such bonus plan being to attract new, and incentivise existing Directors, consultants and employees ("Plan").

 

Under the Plan, subject to achieving the hurdle rate, being equal to a 10% annual increase in the Company's NAV from the value as of 30 June 2015 of US$41.9 million, participants in the Plan receive an allocated proportion ("Award") of an annual cash bonus pool equal to 7.5% of the net increase in the Company's NAV, adjusted for, inter alia, dividends, issue of new shares, share buy-backs, above the previous high watermark, being the Company's highest adjusted NAV prior to the start of the relevant bonus period (the "Net Increase") (the "Bonus Pool"). In 2018, the Company extended the Plan for another three years, until 30 June 2021. The Company's current Plan is due to expire on 30 June 2021.

 

The Board has decided to amend the Plan in order to simplify its administration by bringing the Bonus Pool into line with the Company's financial year end of 31 December and accordingly, the "bonus year-end date" has been amended from 30 June to 31 December.

 

In addition, the Board believes that given the increase in the size of the Company and its team since the Plan was first introduced in 2015, the team's consistent outperformance in growing the Company's NAV and to bring it more in line with typical structures within the venture capital sector in which TMT operates, the quantum of the Bonus Pool should be increased from 7.5% to 10% of the Net Increase in the Company's adjusted NAV, starting from 1 January 2021.

 

Accordingly, the Board has approved the extension of the Company's existing Plan until 31 December 2024, subject to the following material amendments:

· The Company's current bonus year (which was due to end on 30 June 2021) will now run from 1 July 2020 to 31 December 2020;

· The Company's bonus year will then run from 1 January through to 31 December for each of 2021, 2022, 2023 and 2024; and

· From 1 January 2021, the annual Bonus Pool will be increased from 7.5% to 10% of the Net Increase in the Company's adjusted NAV.

 

The minimum initial Award allocation of the Bonus Pool among the predetermined participants of the Plan are also being amended as follows, which will be effective from 1 July 2020:

 

 

% allocation of Bonus Pool

Name

Previous

New

Artemii Iniutin (Employee)

18.25%

16.50%

German Kaplun (Employee)

18.25%

16.50%

Alexander Morgulchik (Employee)

18.25%

16.50%

Alexander Selegenev (Director)

18.25%

16.50%

Yuri Mostovoy (Director)

5.00%

5.00%

Alexander Pak (Employee)

10.00%

10.00%

Levan Kavtaradze (Employee)

6.50%

8.00%

To be allocated

5.50%

11.00%

Total

100.00%

100.00%

 

The beneficiaries of the Plan include Alexander Selegenev and Yuri Mostovoy who are Directors of the Company, and German Kaplun and Alexander Morgulchik who are Substantial Shareholders and hence they are deemed to be related parties pursuant to the AIM Rules. Accordingly, the extension to and amendment of the Plan represents a related party transaction under Rule 13 of the AIM Rules. The independent Directors, being James Mullins and Petr Lanin, consider, having consulted with the Company's Nominated Adviser Strand Hanson Limited, that the revised terms regarding the amendment and extension of the Plan are fair and reasonable insofar as the Company's shareholders are concerned.

 

This announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

TMT Investments Plc

Alexander Selegenev

Executive Director

www.tmtinvestments.com

 

+44 (0)1534 281 800

(Computershare - Company Secretary)

 

alexander.selegenev@tmtinvestments.com

 

Strand Hanson Limited (Nominated Adviser)

Richard Tulloch / James Bellman

 

+44 (0)20 7409 3494

Hybridan LLP (Broker)

Claire Louise Noyce

 

+44 (0)20 3764 2341

Kinlan Communications

David Hothersall

+44 (0)20 7638 3435

davidh@kinlan.net

 

About TMT Investments Plc

 

TMT Investments Plc invests in high-growth technology companies across a number of core specialist sectors and has a significant number of Silicon Valley investments in its portfolio. Founded in 2010, TMT has invested in over 60 companies to date and has net assets of US$101m as of 30 June 2020. The Company's objective is to generate an attractive rate of return for shareholders, predominantly through capital appreciation. The Company is traded on the AIM market of the London Stock Exchange.

 

www.tmtinvestments.com

 

Twitter

 

LinkedIn

 

Facebook

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAXFLASPEFFA
Date   Source Headline
15th Oct 202012:15 pmRNSHolding(s) in Company
15th Sep 20207:00 amRNSHalf-year Report
30th Jul 20204:10 pmRNSResult of AGM
22nd Jul 20207:00 amRNSChange of venue for AGM
15th Jul 20207:00 amRNSPDMR Shareholding
15th Jul 20207:00 amRNSHolding(s) in Company
29th Jun 202011:30 amRNSChange of registered address
25th Jun 20201:35 pmRNSHolding(s) in Company
24th Jun 20203:49 pmRNSHolding(s) in Company
28th May 20207:00 amRNSPortfolio Update
26th May 20203:25 pmRNSPDMR Shareholding
16th Apr 20207:00 amRNSFinal Results and Notice of AGM
31st Mar 20207:00 amRNSUpdate re COVID-19 and Annual Accounts
6th Mar 20202:15 pmRNSPDMR Shareholding
20th Jan 20207:00 amRNSPortfolio Update
27th Dec 20193:29 pmRNSPDMR Shareholding
17th Oct 20194:40 pmRNSHolding(s) in Company
17th Oct 20192:37 pmRNSHolding(s) in Company
17th Sep 20197:00 amRNSHalf-year Report
22nd Aug 20197:00 amRNSPortfolio Update
30th Jul 20193:00 pmRNSResult of Annual General Meeting
10th Jul 201912:32 pmRNSDirector/PDMR Shareholding
9th Jul 20197:00 amRNSDividend Declaration
28th Jun 20197:00 amRNSPortfolio Update
27th Jun 20197:00 amRNSAnnual Financial Report and Notice of AGM
21st Jun 20199:30 amRNSLaunch of new website
26th Feb 20197:00 amRNSInvestment in MEL Science
11th Jan 20197:00 amRNSReceipt of $22.3 million in respect of disposal
2nd Jan 20197:00 amRNSDisposal of interest in Wrike and portfolio update
30th Nov 20182:52 pmRNSPortfolio company update
2nd Nov 20187:00 amRNSChange of Adviser
31st Oct 20181:45 pmRNSHolding(s) in Company
23rd Oct 20187:00 amRNSStatement re Portfolio Update
20th Aug 20187:00 amRNSDirector/PDMR Shareholding
16th Aug 20187:00 amRNSHalf-year Report
5th Jul 20187:00 amRNSInvestor Presentation
30th May 20187:00 amRNSStatement re Portfolio Revaluations
30th Apr 20184:45 pmRNSTotal Voting Rights
27th Apr 20181:28 pmRNSResult of AGM
29th Mar 201812:02 pmRNSConfirmation of Subscription
29th Mar 20187:00 amRNSPlacing and Proposed Subscription
15th Mar 20181:50 pmRNSNotice of AGM
15th Mar 20189:00 amRNSFinal Results
23rd Feb 20187:00 amRNSNotice of Results
21st Feb 20187:00 amRNSTMT Participation in Telegram Group, Inc. Pre-ICO
9th Jan 20185:52 pmRNSDirector/PDMR Shareholding
8th Jan 20183:11 pmRNSStmnt re Share Price Movement
7th Dec 20177:00 amRNSProposed participation in a new fund
17th Nov 20179:14 amRNSHolding(s) in Company
17th Nov 20178:13 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.